Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Cryo-EM
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Cryo-EM
Emergency use authorization Experimental Antiviral Jan/23/2023
Remdesivir
Cryo-EM
Approved by FDA Experimental Antiviral Jan/18/2023
EXO-CD24
Cryo-EM
Potential treatment - clinical evidence Experimental Other treatment Jul/13/2022
Bamlanivimab
Cryo-EM
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Cryo-EM
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
S309
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
BNT162b2
Cryo-EM
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Cryo-EM
Emergency use authorization Experimental Vaccine Jun/22/2022
Cilgavimab
Cryo-EM
Emergency use authorization Experimental Antiviral Jun/18/2022
Tixagevimab
Cryo-EM
Emergency use authorization Experimental Antiviral Jun/18/2022
P2C-1F11
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
hu33
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
S2K146
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022
mAb 222
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-55
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-29
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb 58
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-54
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb 253
Cryo-EM
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022